Disease/Infection News

RSS

New, improved drugs can boost body's natural flu killer system

A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have shown recently that another, more promising, approach is to focus on improving drugs that boost the body's natural flu killer system.

24 May 2013

Findings highlight importance of IL-21 in the development of antiviral vaccines

Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.

24 May 2013

Novel multiplex immunoassay approach to capture HIV antibodies

Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies and can measure even small amounts of multiple antibodies at one time.

24 May 2013

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

Major news outlets in recent days have reported that U.S. Department of Health and Human Services Secretary Kathleen Sebelius is raising money from the private sector -- including from health care executives -- for use by a private entity that is helping to implement ObamaCare. ... Is Ms. Sebelius raising funds for a private entity and then coordinating with that entity to do something Congress has refused to authorize, or for which it has refused to appropriate funds?

24 May 2013

New campaign aims to increase awareness of HIPAA rights, benefits among HIV-positive Black MSM

The U.S. Department of Health and Human Services, Office for Civil Rights is proud to launch the Information Is Powerful Medicine campaign.

24 May 2013

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company developing innovative medicines for the treatment of viral infections, today announced that it has initiated dosing in a Phase I study of SB 9200, its investigational, once daily, oral therapy for the treatment of HCV infection.

24 May 2013

Neisseria meningitidis causes life threatening meningitis, meningococcal sepsis in humans

"Neisseria meningitidis is an important human pathogen that can cause rapidly progressing, life threatening meningitis and meningococcal sepsis in humans," Professor Jennings said.

24 May 2013

CCSC, HHS honor hospitals, health care facilities for preventing HAIs

The Critical Care Societies Collaborative, in partnership with the U.S. Department of Health and Human Services, announces recipients in the 2013 National Awards Program to Recognize Achievements in Eliminating Health Care-Associated Infections.

24 May 2013

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

In an age when microbial pathogens are growing increasingly resistant to the conventional antibiotics used to tamp down infection, a team of Wisconsin scientists has synthesized a potent new class of compounds capable of curbing the bacteria that cause staph infections.

24 May 2013

Hospitals earn nearly nine times more for treating patients who develop CLABSIs, study reports

Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units.

23 May 2013

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

Today, at the World Health Assembly, top health officials from New Zealand, South Africa, Australia, Fiji and Rwanda met to discuss the vital need for countries to integrate rheumatic fever and rheumatic heart disease prevention and control into national action plans.

23 May 2013

AASLD members at forefront to raise awareness of hepatitis B and C

Viral hepatitis is an asymptomatic disease affecting more than 5.3 million Americans. More than 75 percent of those with hepatitis C are unaware they have the virus.

23 May 2013

Scientists make important step forward in the quest to develop universal influenza vaccine

A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets.

23 May 2013

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

The University of Gothenburg Vaccine Research Institute (GUVAX) announces successful results in a placebo controlled phase I study of an oral, inactivated Escherichia coli diarrhea vaccine.

22 May 2013

iBio announces production of vaccine candidate for new H7N9 influenza virus

iBio, Inc. today announced the production of a vaccine candidate for the newly emerged H7N9 influenza virus by an independent third party laboratory using the iBioLaunch platform.

22 May 2013

Lindsley F. Kimball Research Institute receives grant for global health and development research project

The Lindsley F. Kimball Research Institute of the New York Blood Center announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

22 May 2013

RyMed's InVision-Plus neutral connector reduces CRBSIs by 33.3% at Johns Hopkins center

Research on different types of IV connectors led a Johns Hopkins cancer center to pilot a "neutral pressure" IV connector, according to a scientific presentation at the annual meeting of the Oncology Nursing Society.

22 May 2013

New search tool to help doctors make right diagnosis for patients with rare diseases

If you hear the sound of galloping hooves behind you, your immediate reaction is, 'here comes a horse'. But in very rare cases it is actually a zebra approaching. Doctors are trained to think 'horse' or 'common disease' when they meet patients in their practices, and as they rarely or never meet a 'zebra', in the form of a rare disease, it often takes many years to reach the right diagnosis. A new search tool called FindZebra can dramatically reduce this time in many cases.

22 May 2013

Rice University computational study tracks regulatory mechanisms of E. coli cells

Environment is not the only factor in shaping regulatory patterns -- and it might not even be the primary factor, according to a new Rice University study that looks at how cells' protein networks relate to a bacteria's genome.

22 May 2013

Experts urge baby boomers to get screened for HCV

If you're a baby boomer, you may not know that odds are high that you're carrying the hepatitis C virus, putting yourself at risk for illness that can range from minor to life threatening.

22 May 2013

Disease/Infection News

New, improved drugs can boost body's natural flu killer system

Findings highlight importance of IL-21 in the development of antiviral vaccines

Novel multiplex immunoassay approach to capture HIV antibodies

Viewpoints: Sen. Alexander sees reflections of Oliver North in Sebelius' quest to raise funds; vaccine scare's legacy

New campaign aims to increase awareness of HIPAA rights, benefits among HIV-positive Black MSM

Spring Bank Pharmaceuticals starts Phase I study of SB 9200 for treatment of HCV infection

Neisseria meningitidis causes life threatening meningitis, meningococcal sepsis in humans

CCSC, HHS honor hospitals, health care facilities for preventing HAIs

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

Hospitals earn nearly nine times more for treating patients who develop CLABSIs, study reports

Health officials discuss new strategies to prevent rheumatic fever, rheumatic heart disease

AASLD members at forefront to raise awareness of hepatitis B and C

Scientists make important step forward in the quest to develop universal influenza vaccine

GUVAX reports successful results in phase I study of oral, Escherichia coli diarrhea vaccine

iBio announces production of vaccine candidate for new H7N9 influenza virus

Lindsley F. Kimball Research Institute receives grant for global health and development research project

RyMed's InVision-Plus neutral connector reduces CRBSIs by 33.3% at Johns Hopkins center

New search tool to help doctors make right diagnosis for patients with rare diseases

Rice University computational study tracks regulatory mechanisms of E. coli cells

Experts urge baby boomers to get screened for HCV

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News